In this study, we have analysed the prevalence of PALB2 mutations in a cohort of 122 familial breast cancer cases who have previously been tested negative for germline mutations in BRCA1 and BRCA2 and determined the prevalence of selected mutations in a further unselected cohort of breast cancer cases and controls from Malaysia and Singapore. The gene discussed is BRCA1; the disease is breast cancer.